Dr. M. Charles Liberman is the Schuknecht Professor of Otology and Laryngology at the Harvard Medical School and the Director of the Eaton-Peabody Laboratories at the Massachusetts Eye and Ear, one of the largest and best-known research groups devoted to the study of hearing and deafness. The laboratory comprises 27 investigators, with research foci spanning all aspects of the auditory system from sound transmission in the middle ear, through signal transduction in the inner ear and neural processing in the central nervous system. Dr. Liberman received his B.A. in Biology from Harvard College in 1972 and his Ph.D. in Physiology from Harvard Medical School in 1976. He has been on the faculty at Harvard since 1979, has published over 160 papers on a variety of topics in auditory neuroscience and is the recipient of the Award of Merit from the Association for Research in Otolaryngology, the Carhart Award from the American Auditory Society and Bekesy Silver Medal from the Acoustical Society of America. His research interests include 1) coding of acoustic stimuli as neural responses, 2) efferent feedback control of the auditory periphery, 3) mechanisms underlying noise-induced hearing loss, 4) the signaling pathways mediating nerve survival in the inner ear and 5) application of cell- and drug-based therapies to the repair of a damaged inner ear.

Dr. Gabriel Corfas is a professor in the Department of Otolaryngology-Head and Neck Surgery and the director of the Kresge Hearing Research Institute (KHRI) at the University of Michigan. The KHRI is one of the first and leading multidisciplinary centers for the study of hearing, deafness and balance disorders. Before joining the KRHI, Dr. Corfas was a professor of both neurology and otology & laryngology at Harvard Medical School and the director of basic research in otolaryngology at Boston Children’s Hospital. His research focuses on the molecular mechanisms involved in the development, function and maintenance of the nervous system and in using this knowledge to understand nervous system disorders and develop new therapies to treat them. He has published more than 80 papers on the different aspects of neuroscience. Dr. Corfas holds a M.Sc. in biological sciences from the University of Buenos Aires, Argentina, and a Ph.D. in neurobiology from the Weizmann Institute of Science in Israel.

Dr. Ulrich Müller is the Bloomberg Distinguished professor at John Hopkins University. Prior to JHU, he served as Kershaw Professor of Neuroscience; chair of the Department of Molecular & Cellular Neuroscience; director of the Dorris Neuroscience Center; and a member of the Skaggs Institute for Chemical Biology at the Scripps Research Institute.  His research focuses on the molecular mechanisms of auditory perception and analyzing the mechanisms that regulate the development and function of the mammalian neocortex. Prior to joining Scripps, Dr. Müller was a senior staff member and research group leader at the Friedrich Miescher Institute in Basel, Switzerland. He is a member of the American Society for Physiology, American Society for the Advancement in Science, American Society for Neuroscience and the Association of Research in Otolaryngology. Dr. Müller received a diploma and Ph.D. in biology from Albertus Magnus University, Cologne (Germany), and conducted Ph.D. training at Princeton University. He was a post-doctoral fellow at the Howard Hughes Medical Institute and the University of California San Francisco in the laboratory of Dr. L.F. Reichardt.

Dr. Albert Edge is a professor of otology and laryngology at Harvard Medical School (HMS) and the director of the Tillotson Cell Biology Unit at the Massachusetts Eye and Ear (MEE). He was previously an assistant professor at HMS and the Joslin Diabetes Center, and in 2003 took his current position at MEE. He works on stem cell differentiation and regeneration of the inner ear and has identified developmental pathways that are effective in converting stem cells into cochlear hair cells and neurons. Prior to his current position, Dr. Edge was at Diacrin where he was senior director of cell and molecular biology, and at Dyax where he was vice president of discovery research. He received his Ph.D. in biochemistry from Albany Medical College and was a postdoctoral fellow in the Department of Biological Chemistry at HMS.